Skip to main content
Caplight Logo









Duoning Biotechnology

Duoning Biotechnology

Private
ShanghaiHealthcare & Life Scienceshttps://duoningbio.com

Last Round

Private Equity

Mar 1, 2023

Est. Valuation

$1.46B

Total Funding Raised

$16.34M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Duoning Biotechnology operates in Healthcare & Life Sciences and is based in Shanghai. Its latest recorded funding round was a Private Equity round in March 2023.

Duoning Biotechnology is a biotechnology company that provides comprehensive solutions for the research, development, and commercialization of biologics products, offering a wide range of reagents, consumables, and equipment to support bioprocess and laboratory R&D.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Biotech Equipment, Pharma Supply Chain, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Duoning Biotechnology Comparables

Compare Duoning Biotechnology with similar companies based on industry and business-model similarity.

Duoning Biotechnology comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
百林科
88%
Suzhou Womei Biology Co., Ltd.
84%
Sartorius Aktiengesellschaft
80%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Duoning Biotechnology Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Private EquityMar 1, 2023
Series CNov 24, 2021
Series BDec 30, 2020
Series A ExtensionApr 24, 2019
Series ASep 29, 2018
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Duoning Biotechnology Investors

Notable investors and investment history

Duoning Biotechnology investors
InvestorRounds
Huitianfu Fund Management Co., Ltd.Series C
Lake Bleu CapitalSeries C, Series B
GL Capital GroupSeries C
Ally Bridge GroupSeries A Extension
HongShan Capital Group (HSG)Series C, Series B
China Asset Management Co., Ltd.Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 47% MoM.

  • Apr 17, 2026

    Monthly visitors increased 189% MoM.

Book a demo to see all signals

For institutional investors. Book with your work email.

Recent news

Latest coverage and updates

  • attends_eventNov 5, 2026

    Duoningbio participates in analytica China 2026 alongside RephiLe in China from Nov 16th-18th '26.

Book a demo to see all news

For institutional investors. Book with your work email.

Duoning Biotechnology Filings

Explore SEC and related filing metadata, where available.

Duoning Biotechnology filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Duoning Biotechnology's valuation, stock price, and market status.

Is Duoning Biotechnology a public or private company?

Duoning Biotechnology is a private company.

What is the current stock price of Duoning Biotechnology?

Duoning Biotechnology is a private company, so its shares have no public market price. Caplight tracks Duoning Biotechnology's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Duoning Biotechnology worth (valuation)?

Duoning Biotechnology's valuation is estimated at $1.5B based on funding round data.

Can I buy Duoning Biotechnology stock?

Duoning Biotechnology shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Duoning Biotechnology's last funding round?

Duoning Biotechnology's most recent funding round was Private Equity on March 1, 2023.

Who are the main investors in Duoning Biotechnology?

Key investors in Duoning Biotechnology include Huitianfu Fund Management Co., Ltd., Lake Bleu Capital, GL Capital Group, Ally Bridge Group, HongShan Capital Group (HSG).

Will Duoning Biotechnology IPO soon?

No public IPO plans have been announced for Duoning Biotechnology.

How can I track Duoning Biotechnology secondary market activity?

Caplight tracks bids, offers, and trades in Duoning Biotechnology's shares on secondary markets.

Firmographic Details

HeadquartersShanghai
Employee Range24
Year Founded2005
Last FundingMar 1, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?